elevance health inc. - ELV

ELV

Close Chg Chg %
425.82 -7.57 -1.78%

Closed Market

418.25

-7.57 (1.78%)

Volume: 1.40M

Last Updated:

Nov 9, 2026, 3:59 PM EDT

Company Overview: elevance health inc. - ELV

ELV Key Data

Open

$427.43

Day Range

416.63 - 428.22

52 Week Range

274.84 - 450.69

Market Cap

$93.34B

Shares Outstanding

216.06M

Public Float

215.55M

Beta

0.63

Rev. Per Employee

N/A

P/E Ratio

18.42

EPS

$23.55

Yield

161.41%

Dividend

$1.72

EX-DIVIDEND DATE

Dec 4, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.50M

 

ELV Performance

1 Week
 
-1.73%
 
1 Month
 
1.34%
 
3 Months
 
6.10%
 
1 Year
 
31.62%
 
5 Years
 
-4.29%
 

ELV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 25
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 478.714
Number of Ratings 25 Current Quarters Estimate 2.081
FY Report Date 12 / 2026 Current Year's Estimate 29.051
Last Quarter’s Earnings 6.99 Median PE on CY Estimate N/A
Year Ago Earnings 30.29 Next Fiscal Year Estimate 30.248
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 22 16 23 22
Mean Estimate 2.08 12.41 29.05 30.25
High Estimates 3.22 13.67 30.28 31.75
Low Estimate 1.64 8.69 27.20 29.00
Coefficient of Variance 14.11 9.05 1.70 1.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 13
OVERWEIGHT 4 4 4
HOLD 9 9 8
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Elevance Health Inc. - ELV

Date Name Shares Transaction Value
Oct 7, 2026 Mark B. Kaye EVP & CFO 27,876 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $386.43 per share 10,772,122.68
Oct 7, 2026 Mark B. Kaye EVP & CFO 30,503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Elevance Health Inc. in the News